A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castrationresistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment
Số trang: 8
Loại file: pdf
Dung lượng: 1.16 MB
Lượt xem: 5
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Inflammatory cytokine markers, including the neutrophil-to-lymphocyte ratio (NLR), monocytelymphocyte ratio, and platelet-to-lymphocyte ratio, play important roles as prognostic markers in several solid malignancies, including prostate cancer.
Nội dung trích xuất từ tài liệu:
A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castrationresistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment
Nội dung trích xuất từ tài liệu:
A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castrationresistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Abiraterone acetate Inflammatory cytokine markers Monocytelymphocyte ratio Several solid malignancies Including prostate cancerTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 120 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 38 0 0 -
13 trang 38 0 0